2022 annual financial data
Emergent BioSolutions 2022 Operating cash flow margin
Direct answer
Operating cash flow margin was -3.05%.
Operating income was -170,000,000 USD and net income was -211,600,000 USD.
Operating cash flow was -34,100,000 USD.
Get free Emergent BioSolutions email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,117,500,000 USD
- Operating income
- -170,000,000 USD
- Net income
- -211,600,000 USD
- Operating cash flow
- -34,100,000 USD